Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 6, 2013
Cisplatin and radiotherapy with or without erlotinib in locally advanced squamous cell carcinoma of the head and neck: a randomized phase II trialRenato G Martins, Upendra Parvathaneni, Julie E Bauman, et al.
Cancers|July 29, 2023
The Judicious Use of Stereotactic Ablative Radiotherapy in the Primary Management of Localized Renal Cell CarcinomaAndrew B Barbour, Simon Kirste, Anca-Liga Grosu, et al.
Future Oncology (London, England)|September 11, 2024
Focal therapy for oligometastatic and oligoprogressive renal cell carcinoma: a narrative reviewAugust C Anderson, Joel Ho, Evan T Hall, et al.
Advances in Radiation Oncology|April 7, 2022
A Prospective Study of a Resorbable Intravesical Fiducial Marker for Bladder Cancer Radiation TherapyMatthew D Greer, Stephanie K Schaub, Stephen R Bowen, et al.
International Journal of Particle Therapy|November 1, 2021
Consensus Statement on Proton Therapy for Prostate CancerCurtis M Bryant, Randal H Henderson, R Charles Nichols, et al.
Head & Neck|April 25, 2025
Dual PD-1 and CTLA4 Immune Checkpoint Blockade and Hypofractionated Radiation in Patients With Advanced Salivary Gland CancersCristina P Rodriguez, Qian Vicky Wu, Kevin Ng, et al.
Clinical Genitourinary Cancer|September 12, 2024
Small Cell Bladder Cancer: Treatment Patterns for Local Disease and Associated Outcomes. A Retrospective Cohort StudyDimitra Rafailia Bakaloudi, Elizabeth L Koehne, Leonidas N Diamantopoulos, et al.
Urologic Oncology|May 2, 2025
Prospective evaluation of comprehensive geriatric assessments in multidisciplinary bladder cancer care and implications for personalized vulnerability phenotypingDana Cavanaugh, Sarah K Holt, Erin Dwyer, et al.
Lancet (London, England)|December 14, 2025
Proton versus photon radiotherapy for patients with oropharyngeal cancer in the USA: a multicentre, randomised, open-label, non-inferiority phase 3 trialSteven J Frank, Paul M Busse, J Jack Lee, et al.
Pageof 5